ClinicalTrials.gg
CompletedNCT06805578ReCognitionUpdated Jun 15, 2026

Exploring and Evaluating the Impact of 'Refresh and Reconnect!'

An interventional study of Heritage art programme in Mild Cognitive Impairment (MCI), Ageing and Mild Dementia, sponsored by Duke-NUS Graduate Medical School. Completed at 1 site in Singapore. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-06-15.

Sponsored by Duke-NUS Graduate Medical School · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
108
Allocation
Not applicable
Ages
21 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 42 studies in Cognitive Dysfunction with a site in Singapore — 10 open to participants now, 12 under way, 1 of them phase 3. Cognitive Dysfunction · Singapore.

Enrollment
17th of 39
108 · median 82
Started
2025
with 3 others
No phase
23 of 42
7 open now
Registered
34th of 42
by date
Lead sponsor
5 of 42
Duke-NUS Graduate Medical School

Among the 42 studies in Cognitive Dysfunction with a site in Singapore, this one is the 17th largest by enrollment of the 39 interventional ones that give a count, is one of 4 that started in 2025, is one of 23 with no phase, and was the 34th registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

10 of the 42 studies in Cognitive Dysfunction with a site in Singapore are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 21 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Cognitive Dysfunction with a site in Singapore, or all of them as a file.
02

Study summary

Dementia and mild cognitive impairment are a rising concern for the ageing population in Singapore, leading to diminished quality of life and health outcomes. Arts-based interventions in a museum setting have been shown to improve cognitive health and well-being for Persons with Cognitive Impairment (PWCIs), however little is known about the relationship of heritage-based interventions on the health and well-being of PWCIs.

This mixed-methods study evaluates the 6-week "Refresh and Reconnect!" programme (R\&R!), a museum-based heritage programme including guided artist-led activities and tours of the National Museum of Singapore.

(i) In the quantitative study (n = 64-120 PWCIs, comprising with mild cognitive impairment (MCI) or mild dementia), assessments will be conducted at 2 time points (pre-programme, post-programme) to evaluate change in cognitive, social, and mental well-being.

ii) In the qualitative study, ethnographic observations of the R\&R! programme; ethnographic interviews with staff (n= max 3), \& artists (n= max 6); and in-depth interviews with PWCIs (n=16) will be used to elicit the underlying context-mechanisms-outcomes which enable R\&R! success. Programme volunteers will also be engaged through casual or informal conversations as part of the ethnographic observations.

The study will provide valuable insights for the development of effective, non-pharmacological interventions for PWCIs. The primary objectives of the study are to (a) compare the change (before and after programme participation) in the health and well-being of PWCIs participating in the programme, and (b) assess the change (before and after programme participation) in the perception of the museum, 'heritage' and learning among PWCIs participating in the programme. The secondary aims are to understand the factors, contexts, and mechanisms that influence the implementation of the museum-based intervention and its effects, including the place-based effects of the curated museum Reunion space for PWCIs.

Achieving the objectives will help answer the following research questions:

  1. To what extent, and how does participation in the "Refresh and Reconnect!" programme impact health and well-being of PWCIs?
  2. To what extent, and how does participation in the programme affect the study participants' understanding and perception of the museum as a potential place to enhance one's health and well-being? [Note: Study Participants include all who are participating in the study such as PWCIs and those who are implementing (e.g. museum staff), facilitating (e.g. artists) and assisting (e.g. volunteers) with the R\&R! Programme]
  3. What are the contexts and mechanisms that influence the implementation of the programme?

These findings are of significant public health importance for Singapore, potentially informing policy decisions, resource allocation, and healthcare strategies to better support PWCIs, ultimately improving their quality of life. Findings of the study may also contribute to similar heritage-based programmes in future, contributing to the understanding of key elements of programme success, and for whom these programmes are effective for.

03

Conditions studied

  • Mild Cognitive Impairment (MCI)
  • Ageing
  • Mild Dementia
  • Well-being

Keywords

  • Social Prescription
  • Heritage
  • Museum
  • Mild Cognitive Impairment
  • Mild Dementia
  • Person with cognitive impairment
  • Artist
04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Fulfils the programme recruitment criteria and registers for the programme through National Museum of Singapore's collaborating partners; AND
  • Provides consent for participation in the study personally; AND
  • Willing and able to participate in interviews independently, without proxy; AND
  • Scores between 22 to 27 on the (or 22 to 26 for participants with less than 10 years of education; or 22 to 25 for participants who are unable to provide information on the number of years of formal education completed). These thresholds follow the recommendation of MoCA use in determining mild cognitive impairment and mild dementia in Singapore and draw from studies concerning mental capacity and consent for persons living with cognitive impairment

Exclusion criteria

Exclusion Criteria:

  • Whose cognitive impairment status cannot be confirmed by the administered screener; OR
  • Do not give consent to participate in the study; OR
  • Scores below 22 on the , or above 27 (or 26 for participants with less than 10 years of education; or 25 for participants who are unable to provide information on the number of years of formal education completed)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
108 participants (actual)

Study arms

  • Experimental
    Intervention Group

    Persons with cognitive impairment will undergo a 6-week heritage-based intervention programme conducted by the National Museum of Singapore, which includes guided gallery tours led by the museum's Care Facilitator volunteers and artist-led hands-on activities based on various art forms.

    Other: Heritage art programme

Interventions

  • OtherHeritage art programme

    The 6-week 'Refresh and Reconnect!' programme includes guided gallery tours led by the museum's Care Facilitator volunteers and artist-led hands-on activities based on various art forms (e.g. artist-led dance, art, or drama workshops).

    Also known as: "Refresh and Reconnect!"

06

What researchers measure

Primary outcomes

  1. Change from baseline in Quality of life at the end of the 6-week intervention

    Quality of life (QoL) will be assessed using the Control, Autonomy, Self-Realization, and Pleasure-11-SG (CASP-11-SG) scale. CASP-11-SG has been validated in Singapore. It has 11 items covering two domains: Control-Autonomy, and Self-realization-Pleasure (Table 1). Items are scored on a four-point response scale \[Often (score = 3), Sometimes, Not Often, Never (score = 0)\] based on how often the participant feels the way described in the item. Negatively worded items are reverse-coded. A higher total score (range: 0-33) indicates higher QoL. Control-Autonomy subscale (range: 0-18) and Self-realization-Pleasure subscale (range: 0-15) scores are also calculated.

    Time frame: From enrolment to the end of intervention at 6 weeks

  2. Change from baseline in Health-related Quality of life at the end of the 6-week intervention

    Health-related Quality of life (HRQoL) will be assessed using the EuroQol- 5 Dimension (EQ-5D) questionnaire. The EQ-5D comprises five questions on mobility, self-care, pain, usual activities, and psychological status with five possible answers for each item (1=no problem, 2=slight problem, 3=moderate problem, 4=severe problem, 5=unable to do). Overall, a total score of 5 indicates the best health state, whereas higher scores indicate more severe or frequent problems. In addition, there is a visual analogue of the scale to indicate general health status, with a score of 100 indicating the best health status.

    Time frame: From enrolment to the end of intervention at 6 weeks

  3. Change from baseline in depression at the end of the 6-week intervention

    Depression will be assessed using the CES-D-11 (Center for Epidemiologic Studies Depression Scale - 11 item version). It is a self-reported rating scale of 11 items on a 3-point Likert scale (range 0-2), with response options for "None/Rarely" (0), "Sometimes" (1), and "Often" (2) based on experiences over the past week. The total score is the sum of the 11 items, ranging from 0 to 22. Reverse Scoring: Positively worded items (e.g., "I felt happy," "I enjoyed life") are reverse scored before summing the total score. For these items, the scoring is: Often (0), Sometimes (1), None/Rarely (2). Scores of ≥9 indicate significant depressive symptoms, 5-8 suggest borderline depressive symptoms, and 0-4 fall within the normal range.

    Time frame: From enrolment to the end of intervention at 6 weeks

  4. Change from baseline in anxiety at the end of the 6-week intervention

    Anxiety will be assessed using the GAD-7 (Generalized Anxiety Disorder-7) Scale. It is a self-reported rating scale consisting of 7 items on a 4-point Likert scale (range 0-3), with response options for "Not at all" (0), "Several days" (1), "More than half the days" (2), and "Nearly every day" (3), based on experiences over the past two weeks. The total score is the sum of the 7 items, ranging from 0 to 21. Higher scores indicate greater anxiety severity. Interpretation: Scores of 0-4 indicate minimal anxiety, 5-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety. A total score of ≥10 is typically used as the threshold for identifying probable generalized anxiety disorder.

    Time frame: From enrolment to the end of intervention at 6 weeks

  5. Change from baseline in loneliness at the end of the 6-week intervention

    Loneliness will be assessed using The Three-Item Loneliness Scale. Each item of the scale has a five-point Likert response option: "Always" (scored as 4) "Fairly Often" (3), "Occasionally" (2), "Rarely" (1), and "Never" (scored as 0). The scores for each individual question can be added together to give a possible range of scores from 0 to 12. Higher scores indicate greater degrees of loneliness.

    Time frame: From enrolment to the end of intervention at 6 weeks

  6. Change from baseline in social isolation at the end of the 6-week intervention

    Lubbens Social Network Scale 6-item (LSNS-6) is a social engagement scale that consists of six items. The score for each item ranges from 0 to 5, with 0 indicating none and 5 indicating nine or more. The total score is calculated by finding the sum of all items, and ranges from 0 to 30. A higher score indicates more social engagement.

    Time frame: From enrolment to the end of intervention at 6 weeks

  7. Change from baseline in ageing perceptions at the end of the 6-week intervention

    The Brief Ageing Perceptions Questionnaire (Brief-APQ) measure comprise Likert scale items that represent seven ageing perception domains. Participants rate their agreement with a series of statements - for example "I am always aware of my age" or "As I get older I can take part in fewer activities" with a five-point response scale with the options: Strongly Disagree, Disagree, Neither Agree nor Disagree, Agree, Strongly Agree.

    Time frame: From enrolment to the end of intervention at 6 weeks

  8. Change from baseline in motivations to learn at the end of the 6-week intervention

    Motivations to learn will be assessed using the Readiness-to-learn Scale from the background questionnaire of the Programme for the International Assessment of Adult Competencies (PIAAC). This scale assesses participants' motivations to learn, and the learning strategies they adopt to solve challenges in learning. The response categories for this item range from not at all (1), to a very high extent (5).

    Time frame: From enrolment to the end of intervention at 6 weeks

  9. Change from baseline in Montreal Cognitive Assessment score at the end of the 6-week intervention

    Cognitive performance will be assessed using the Montreal Cognitive assessment (MoCA). MoCA assessment parameters are visuospatial/ executive, naming ability, vigilance, verbal fluency, delayed recall, and abstractions. The maximum MoCA score is 30 points. MCI (Mild Cognitive Impairment) is indicated by a score of less than 27 for those with 10 or more years of education or a score of less than 26 for those with less than 10 years of education (following the recommendation of MoCA use in Singapore).

    Time frame: From enrolment to the end of intervention at 6 weeks

Secondary outcomes

  1. Changes to subjective well-being after each session of the 6-week intervention

    Museum-based subjective well-being will be assessed by University College London (UCL) Museum Wellbeing Measures toolkit. The toolkit includes a 12-item Generic Wellbeing Questionnaire (GWQ) and Positive Wellbeing Measures Umbrella, designed specifically for museum projects. The GWQ uses statements that refer to an emotion or life quality that participants might have experienced during the museum activity, such as 'I felt confident'. These are rated from 1 ('None of the time') to 5 ('All of the time'). The Positive Wellbeing Umbrella consist of a hexagonal shape with six sections of different colours. Each of the six sections has a word next to it related to a wellbeing mood or emotion and responses are ranged from one (I don't feel) to five (I feel extremely). Participants are required to rate the extent they feel the wellbeing word at that moment in time by circling the appropriate number.

    Time frame: From enrolment to the end of intervention at 6 weeks

07

Study locations

1 site
  • National Museum of Singapore
    Singapore, 178897, Singapore
08

References and documents

Publications

  • Zietlow KE, Oyeyemi DM, Cook SE, Hardy M, McDonald SR, Lagoo-Deenadayalan S, Heflin MT, Whitson HE. RESEARCHCognition and Capacity to Consent for Elective Surgery. J Am Geriatr Soc. 2020 Nov;68(11):2694-2696. doi: 10.1111/jgs.16786. Epub 2020 Aug 17. No abstract available. PubMed 33460037 ↗
  • Yang M, Samper-Ternent R, Volpi E, Green AN, Lichtenstein M, Araujo K, Borek P, Charpentier P, Dziura J, Gill TM, Galloway R, Greene EJ, Lenoir K, Peduzzi P, Meng C, Reese J, Shelton A, Skokos EA, Summapund J, Unger E, Reuben DB, Williamson JD, Stevens AB. The dementia care study (D-CARE): Recruitment strategies and demographic characteristics of participants in a pragmatic randomized trial of dementia care. Alzheimers Dement. 2024 Apr;20(4):2575-2588. doi: 10.1002/alz.13698. Epub 2024 Feb 15. PubMed 38358084 ↗
  • Wu CY, Hung SJ, Lin KC, Chen KH, Chen P, Tsay PK. Responsiveness, Minimal Clinically Important Difference, and Validity of the MoCA in Stroke Rehabilitation. Occup Ther Int. 2019 Apr 14;2019:2517658. doi: 10.1155/2019/2517658. eCollection 2019. PubMed 31097928 ↗
  • Wu VX, Chi Y, Lee JK, Goh HS, Chen DYM, Haugan G, Chao FFT, Klainin-Yobas P. The effect of dance interventions on cognition, neuroplasticity, physical function, depression, and quality of life for older adults with mild cognitive impairment: A systematic review and meta-analysis. Int J Nurs Stud. 2021 Oct;122:104025. doi: 10.1016/j.ijnurstu.2021.104025. Epub 2021 Jun 30. PubMed 34298320 ↗
  • Veretennikoff K, Walker D, Biggs V, Robinson G. Changes in Cognition and Decision Making Capacity Following Brain Tumour Resection: Illustrated with Two Cases. Brain Sci. 2017 Sep 24;7(10):122. doi: 10.3390/brainsci7100122. PubMed 28946652 ↗
  • Teri L, Truax P, Logsdon R, Uomoto J, Zarit S, Vitaliano PP. Assessment of behavioral problems in dementia: the revised memory and behavior problems checklist. Psychol Aging. 1992 Dec;7(4):622-31. doi: 10.1037//0882-7974.7.4.622. PubMed 1466831 ↗
  • Tan SY, Lew KJ, Xie Y, Lee PSS, Koh HL, Ding YY, Lee ES. Healthcare cost of patients with multiple chronic diseases in Singapore public primary care setting. Ann Acad Med Singap. 2021 Nov;50(11):809-817. doi: 10.47102/annals-acadmedsg.2021246. PubMed 34877584 ↗
  • Tan LT, Ostbye T, Visaria A, Malhotra R. Derivation, and establishment of the validity and reliability, of the CASP-11-SG quality of life scale among community-dwelling older adults. Qual Life Res. 2023 Jan;32(1):295-306. doi: 10.1007/s11136-022-03238-4. Epub 2022 Sep 6. PubMed 36068420 ↗
  • Subramaniam M, Chong SA, Vaingankar JA, Abdin E, Chua BY, Chua HC, Eng GK, Heng D, Hia SB, Huang W, Jeyagurunathana A, Kua J, Lee SP, Mahendran R, Magadi H, Malladi S, McCrone P, Pang S, Picco L, Sagayadevan V, Sambasivam R, Seng KH, Seow E, Shafie S, Shahwan S, Tan LL, Yap M, Zhang Y, Ng LL, Prince M. Prevalence of Dementia in People Aged 60 Years and Above: Results from the WiSE Study. J Alzheimers Dis. 2015;45(4):1127-38. doi: 10.3233/JAD-142769. PubMed 25672767 ↗
  • Siow JYM, Chan A, Ostbye T, Cheng GH, Malhotra R. Validity and Reliability of the Positive Aspects of Caregiving (PAC) Scale and Development of Its Shorter Version (S-PAC) Among Family Caregivers of Older Adults. Gerontologist. 2017 Aug 1;57(4):e75-e84. doi: 10.1093/geront/gnw198. PubMed 28082275 ↗
  • Reschke-Hernandez AE, Gfeller K, Oleson J, Tranel D. Music Therapy Increases Social and Emotional Well-Being in Persons With Dementia: A Randomized Clinical Crossover Trial Comparing Singing to Verbal Discussion. J Music Ther. 2023 Oct 7;60(3):314-342. doi: 10.1093/jmt/thad015. PubMed 37220880 ↗
  • Poulos RG, Marwood S, Harkin D, Opher S, Clift S, Cole AMD, Rhee J, Beilharz K, Poulos CJ. Arts on prescription for community-dwelling older people with a range of health and wellness needs. Health Soc Care Community. 2019 Mar;27(2):483-492. doi: 10.1111/hsc.12669. Epub 2018 Oct 21. PubMed 30345578 ↗
  • Peters S, Lohse KR, Klassen TD, Liu-Ambrose T, Dukelow SP, Bayley MT, Hill MD, Pooyania S, Yao J, Eng JJ. Higher intensity walking improves global cognition during inpatient rehabilitation: a secondary analysis of a randomized control trial. Front Neurol. 2023 Jun 9;14:1023488. doi: 10.3389/fneur.2023.1023488. eCollection 2023. PubMed 37360352 ↗
  • Nowell, L. S., Norris, J. M., White, D. E., & Moules, N. J. (2017). Thematic Analysis: Striving to Meet the Trustworthiness Criteria. International Journal of Qualitative Methods, 16(1). https://doi.org/10.1177/1609406917733847
  • Ng A, Chew I, Narasimhalu K, Kandiah N. Effectiveness of Montreal Cognitive Assessment for the diagnosis of mild cognitive impairment and mild Alzheimer's disease in Singapore. Singapore Med J. 2013 Nov;54(11):616-9. doi: 10.11622/smedj.2013220. PubMed 24276096 ↗
  • Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. doi: 10.1111/j.1532-5415.2005.53221.x. PubMed 15817019 ↗
  • National Population and Talent Division (2023). Population in Brief 2023: Key Trends. Strategy Group, Prime Minister's Office. https://www.population.gov.sg/media-centre/articles/population-in-brief-2023-key-trends/
  • Musek, J., Polic, M. (2014). Personal Well-Being. In: Michalos, A.C. (eds) Encyclopaedia of Quality of Life and Well-Being Research. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0753-5_2148
  • Mollers T, Perna L, Stocker H, Ihle P, Schubert I, Schottker B, Frolich L, Bauer J, Brenner H. Alzheimer's disease medication and outcomes of hospitalisation among patients with dementia. Epidemiol Psychiatr Sci. 2019 Nov 14;29:e73. doi: 10.1017/S2045796019000702. PubMed 31722770 ↗
  • Karlawish J, Cary M, Moelter ST, Siderowf A, Sullo E, Xie S, Weintraub D. Cognitive impairment and PD patients' capacity to consent to research. Neurology. 2013 Aug 27;81(9):801-7. doi: 10.1212/WNL.0b013e3182a05ba5. Epub 2013 Jul 26. PubMed 23892706 ↗
  • Jiao Y, Liu C, Chang J, Zhou S, Ji Y. Self-management preferences in patients with mild cognitive impairment: A qualitative study. Front Psychol. 2022 Oct 14;13:955960. doi: 10.3389/fpsyg.2022.955960. eCollection 2022. PubMed 36312202 ↗
  • Ito E, Nouchi R, Dinet J, Cheng CH, Husebo BS. The Effect of Music-Based Intervention on General Cognitive and Executive Functions, and Episodic Memory in People with Mild Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Recent Randomized Controlled Trials. Healthcare (Basel). 2022 Aug 3;10(8):1462. doi: 10.3390/healthcare10081462. PubMed 36011119 ↗
  • Hawkley LC, Browne MW, Cacioppo JT. How can I connect with thee? Let me count the ways. Psychol Sci. 2005 Oct;16(10):798-804. doi: 10.1111/j.1467-9280.2005.01617.x. PubMed 16181443 ↗
  • Gorges, J., Maehler, D.B., Koch, T., & Offerhaus, J. (2016). Who likes to learn new things: measuring adult motivation to learn with PIAAC data from 21 countries. Large-scale Assessments in Education, 4, 9. https://doi.org/10.1186/s40536-016-0024-4
  • Gordon MF, Lenderking WR, Duhig A, Chandler J, Lundy JJ, Miller DS, Piault-Louis E, Doody RS, Galasko D, Gauthier S, Frank L; Patient-Reported Outcome Consortium's Cognition Working Group. Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase. Alzheimers Dement. 2016 Jan;12(1):75-84. doi: 10.1016/j.jalz.2015.04.008. Epub 2015 Jun 13. PubMed 26079412 ↗
  • Givon Schaham N, Buckman Z, Rand D. TECH preserves global cognition of older adults with MCI compared with a control group: a randomized controlled trial. Aging Clin Exp Res. 2024 Jan 20;36(1):1. doi: 10.1007/s40520-023-02659-6. PubMed 38252189 ↗
  • Forward Singapore Workgroup. (2023). Building our shared future. https://www.forwardsingapore.gov.sg
  • EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208. doi: 10.1016/0168-8510(90)90421-9. PubMed 10109801 ↗
  • Dinius CJ, Pocknell CE, Caffrey MP, Roche RAP. Cognitive interventions for memory and psychological well-being in aging and dementias. Front Psychol. 2023 Feb 2;14:1070012. doi: 10.3389/fpsyg.2023.1070012. eCollection 2023. PubMed 36818134 ↗
  • Cowan, B., Laird, R., & McKeown, J. (2019). Museum Objects, Health and Healing: The Relationship between Exhibitions and Wellness (1st ed.). Routledge. https://doi.org/10.4324/9780429467813
  • Cobb, G.H. (2022). Understanding adult play and wellbeing in children's museums. MuseumsForward, 2(4).
  • Chiang KJ, Chu H, Chang HJ, Chung MH, Chen CH, Chiou HY, Chou KR. The effects of reminiscence therapy on psychological well-being, depression, and loneliness among the institutionalized aged. Int J Geriatr Psychiatry. 2010 Apr;25(4):380-8. doi: 10.1002/gps.2350. PubMed 19697299 ↗
  • Bennington, R., Backos, A., Harrison, J., Etherington Reader, A., & Carolan, R. (2016). Art therapy in art museums: Promoting social connectedness and psychological well-being of older adults. The Arts in Psychotherapy, 49, 34-43. https://doi.org/10.1016/j.aip.2016.05.013
  • An S, Ko J, Yu KS, Kwon H, Kim S, Hong J, Kong HJ. Exploring the Category and Use Cases on Digital Therapeutic Methodologies. Healthc Inform Res. 2023 Jul;29(3):190-198. doi: 10.4258/hir.2023.29.3.190. Epub 2023 Jul 31. PubMed 37591674 ↗
  • Baumann, J., Biscoe, N., Burnell, K., Lobban, J., & Murphy, D. (2023). Museum-based art therapy and wellbeing programme: experiences of veterans with PTSD1. International Journal of Art Therapy, 28(3), 142-149. https://doi.org/10.1080/17454832.2023.2188409

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — The investigator team will decide on sharing of individual participant data on a case-to-case basis, when such requests are made.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in May 2026, 16 months.

Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's 16 months is below that.

Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 28, 2025
First posted
Feb 3, 2025
StartActual
Jan 1, 2025
Primary completionActual
May 20, 2026
CompletionActual
Jun 1, 2026
Last update
Jun 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06805578
Lead sponsor
Duke-NUS Graduate Medical School
Collaborators
National Museum of Singapore, National Heritage Board, Singapore
Responsible party
Rahul Malhotra (Associate Professor, Duke-NUS Graduate Medical School) — Principal investigator
First posted
Feb 3, 2025
Start date
Jan 1, 2025
Primary completion
May 20, 2026
Completion
Jun 1, 2026
Last update
Jun 15, 2026

Study contacts

Rahul Malhotra, MD, MPH
principal investigator · Duke-NUS Graduate Medical School
Ad Maulod, PhD, MSc
principal investigator · Duke-NUS Graduate Medical School

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion